Facebook Twitter Youtube Instagram
Contact Us
Menu
Quick updates
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)

Pharmacovigilance Newsletter

Pharmacovigilance & Post-Market Surveillance

The PV/PMS Directorate sends out quarterly newsletters to stakeholders. The objectives of the newsletters are to:

  • Disseminate information on pharmacovigilance activities nationally and globally
  • Educate stakeholders on medicines safety issues
  • Promote rational use of medicines and
  • Promote spontaneous reporting of Adverse Drug Reactions(ADRs)

The newsletters are circulated to stakeholders via email. They can also be accessed below.

Contact us via fdic@nafdac.gov.ng if you would like the Newsletters delivered directly to your mail.

TitleVolumeYear Published
Perils in Preservation, Exploring how Inadequate Storage Conditions Transform Pharmaceuticals into MenacesVol. 17 No. 32024
Best Practices for Disposal of Antimicrobials Amidst the Escalating Threat of Antimicrobial ResistanceVol. 17 No. 22024
Facts About Prescription Opioids, Risks and Management Newsletter DraftVol. 17 No. 12024
Pharmacovigilance Practice by Community Pharmacists Challenges & SolutionsVol. 16 No. 42023
Spontaneous Reporting In A Hospital Setting, Challenges & SolutionsVol. 16 No. 32023
Pharmacovigilance in Public Health ProgrammesVol. 16 No. 22023
Factors that affect the uptake of booster doses of COVID-19 vaccine VolVol. 16 No. 12023
Recent Developments in Nigerian Implementation of Good Distribution Practices of Pharmaceutical ProductsVol. 15 No. 12022
New Developments And Activities Of The National Pharmacovigilance Centre In The Year 2020 And 2021Vol. 14 No. 22021
Pharmacovigilance A View Of Medical DevicesVol. 13 No. 32020
Regulation And Control Of Medical Product In A PandemicVol. 13 No. 22020
Fluoroquinolones and risk of disabling and potentially irreversible side effectsVol. 13 No. 12020
Circulation of falsified antimalaria and antibiotics in subsaharan AfricaVol. 12 No. 22019
Activities At The National Pharmacovigilance Center In The Year 2018Vol. 12 No. 12019
Sulfadoxine/Pyrimethamine and Stevens-Johnson SyndromeVol. 11 No. 12018
Review of Pediatric PharmacovigilanceVol. 9 No. 12016
Rational use of MedicinesVol. 8, No. 12015
Pharmacovigilance of Antidiabetic DrugsVol. 7 No. 32014
Antibiotic Resistance and PharmacovigilanceVol. 7 No. 22014
Overview of Tuberculosis Infection and DiseaseVol. 7 No. 12014
Pharmacovigilance of VaccinesVol. 6 No. 22013
National Pharmacovigilance PolicyVol. 6 No. 12013
Pharmacovigilance of Act AntimalarialsVol. 5 No. 32011
Stevens Johnson SyndromeVol. 5 No. 22011
Pharmacovigilance and the Use of AntibioticsVol. 4 No. 32010
Pharmacovigilance of Antihypertensive MedicinesVol. 4 No. 12010
Pharmacovigilance of Antiretroviral MedicinesVol. 3 No. 32009
A Description of ADRs Received by the NPC That Were due to AnalgesicsVol. 1 No. 42008
Summary of Spontaneous Adverse Drug Reactions (ADR) Reports Received on Antibiotics UsageVol. 1 No. 32008
Zonal Training Workshop for Institutional Drug Safety Monitoring OfficersVol. 2 2007
Introducing The PVG/FDIC NewsletterVol. 1 No. 1 2007

Was this helpful?

Yes
No
Thanks for your feedback!
  • Content Current as of September 24, 2024

More Actions

About NAFDAC

Useful Links

NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND CONTROL (NAFDAC)

This is the Official Website of Nafdac, the Agency commissioned to protect and promote the public health by instituting an effective and efficient regulatory system that ensures only the right quality food, drugs and other regulated products are manufactured, exported, imported, advertised, distributed, sold, and used

Contact us

  • NAFDAC Corporate Headquarters, Plot 2032, Olusegun, Obasanjo Way, Zone 7, Wuse, Abuja, Nigeria
  • Lagos Operation Office: Plot 1, Industrial Estate, Lagos- Oshodi Apapa Express Way, Isolo, Lagos, Nigeria
Facebook X-twitter Youtube

For enquires

For complaints

Subscribe to Our Newsletter

Privacy Policy

Products We Regulate

For Industry

For Consumers

About Nafdac

Useful Links